Liothyronine and Sodium zirconium cyclosilicate interaction
Liothyronine and Sodium zirconium cyclosilicate: the Sodium zirconium cyclosilicate prescribing label mentions this combination without an instruction to avoid it or change the dose.
Minor
Mentioned, no instruction to avoid. Worth knowing; rarely a reason to change anything on its own.
What the FDA labels say
From the Sodium zirconium cyclosilicate (LOKELMA) label · effective 2026-03-26
Minor
Losartan, glipizide and levothyroxine did not show any changes in exposure when co-administered with LOKELMA.
Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.
Open in the checkerNot medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.